Atara Biotherapeutics (ATRA) Cash from Operations (QoQ) (2014 - 2026)
Atara Biotherapeutics (ATRA) Cash from Operations (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,827.19 Bn | 1,827.13 Bn | - |
| 2 | Akari Therapeutics | 1,006.47 Bn | 1,006.47 Bn | - |
| 3 | BeOne Medicines | 475.45 Bn | 470.65 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.31 Bn | 62.56 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.61 Bn | 62.61 Bn | - |
| 7 | Argenx Se | 55.56 Bn | 50.38 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 37.96 Bn | 34.96 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 37.20 Bn | 37.20 Bn | - |
| 10 | Atara Biotherapeutics | 109.27 Mn | 100.91 Mn | 392,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.06% |
| Dec 31, 2025 | 41.79% |
| Sep 30, 2025 | -33.74% |
| Jun 30, 2025 | 73.99% |
| Mar 31, 2025 | -14.99% |
| Dec 31, 2024 | -513.46% |
| Sep 30, 2024 | 62.53% |
| Jun 30, 2024 | 64.05% |
| Mar 31, 2024 | 41.25% |
| Dec 31, 2023 | 1.83% |
| Sep 30, 2023 | 2.75% |
| Jun 30, 2023 | -37.39% |
| Mar 31, 2023 | 32.44% |
| Dec 31, 2022 | 12.57% |
| Sep 30, 2022 | -1.71% |
| Jun 30, 2022 | 24.33% |
| Mar 31, 2022 | -146.66% |
| Dec 31, 2021 | 41.90% |
| Sep 30, 2021 | 4.22% |
| Jun 30, 2021 | 6.27% |